Results 161 to 170 of about 9,442,670 (309)

CDC Division of Global HIV & TB country profile : Central Asia

open access: yes
The CDC Central Asia Region (CAR) office was formally established at the U.S. Consulate in Almaty, Kazakhstan in 1995 and began directly receiving PEPFAR funds in 2005.

core  

Sección asociada al Master Universitario en "Salud Mujer y Cuidados", del Departamento de Enfermería, en la Facultad de Enfermería de la Universidad de Murcia (España)

open access: yesEnfermería Global, 2011
Revista Enfermería Global
doaj   +1 more source

Taking the neglected out of neglected tropical diseases

open access: yesThe Lancet Global Health, 2020
The Lancet Global Health
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

CDC protects Americans at home and abroad through global health [PDF]

open access: yes
For over 60 years, CDC has provided domestic and global public health leadership all over the world to achieve public health goals and meet emerging health challenges. The foundation of CDC\ue2\u20ac\u2122s global health work is built on rigorous science

core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy